Drug Compounding

This interest group brings together industry leaders involved in 503A and 503B Drug Compounding facilities. The group will focus on fostering collaboration and dialogue surrounding discussions on emerging regulations, best practices, and navigating the landscape of compliance. Topics covered will include production techniques, personnel practices, facility management, control of materials, and application of GMPs in daily operations, ensuring quality for all drug products.  The FDA Compounding Quality Center of Excellence will be participating in the Interest Group, but this forum will not be used to discuss any policy issues or to direct specific questions to the FDA.